Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

Michael R. Migden, Nikhil I. Khushalani, Anne Lynn S. Chang, Karl D. Lewis, Chrysalyne D. Schmults, Leonel F. Hernandez‐Aya, Friedegund Meier, Dirk Schadendorf, Alexander Guminski, Axel Hauschild, Deborah Jean Lee Wong, Gregory A. Daniels, Carola Berking, Vladimir Janković, Elizabeth Stankevich, Jocelyn Booth, Siyu Li, David M. Weinreich, George D. Yancopoulos, Israel Lowy, Matthew G. Fury, Danny Rischin